Venture capital continues to fund AI‑centric biology startups: Breakout Ventures closed a $114 million Fund III to back early‑stage companies translating academic breakthroughs into scalable businesses, with an emphasis on AI‑enabled discovery platforms. The fund targets roughly 20 investments and prioritizes founders fluent in both science and engineering. In parallel, Living Models, a French startup building foundation models for biology trained on DNA, RNA, and multiomic data, raised a $7 million seed round to scale compute resources and expand its Botanic model for plant biology. Living Models plans to translate predictive models into breeding and trait discovery applications. The rounds reflect investor appetite for computational platforms that compress discovery timelines across agriculture and therapeutics, and they signal sustained capital flows into AI‑driven life science ventures despite broader market caution.